BURDEN OF SPINAL DISEASES- RESULTS FROM REGISTER STUDY IN SWEDEN

Author(s)

Olafsson G1, Jonsson E1, Fritzell P2, Hägg O3, Borgström F1
1Quantify Research, Stockholm, Sweden, 2Neuro-orthopedic clinic, Futurum Academy, Jönköping, Sweden, 3Spine Center Göteborg, Gothenburg, Sweden

OBJECTIVES: The objective of this study was to estimate the direct and indirect costs of low back pain with/without radiant pain (LBP) in Sweden using the concept of “LBP-episode”, and to identify the variation of these across different patients groups. METHODS: Patients visiting healthcare providers, or receiving health insurance benefits, with a LBP-diagnosis in the region of Västra Götaland in 2008-2012 were identified in the administrative database VEGA. Data from additional Swedish national registers including inpatient and outpatient care, drug prescriptions, socioeconomics and social security were extracted. The burden was measured for “LBP-episodes”, defined as time periods with consecutive visits to the healthcare system with a relevant diagnosis code, continuing until 6 months have elapsed without costs incurred by LBP-related visits. RESULTS: More than 72,000 patients were identified, with over 95,000 LBP-episodes. The average episode length was 56/176 days in episodes without/with surgery. The mean total cost per episode was estimated at €5,453, where indirect costs constituted 68.4%, medical visits including diagnostic imaging 14.5%, other inpatient care 8.2%, surgery 7.9%, and pharmaceuticals 1.0%. In men/women, the mean total cost per episode was estimated to €22,174/€24,833 in episodes with surgery, and €4,175/€3,957 in episodes without surgery. The total burden of LBP in Sweden in 2012 was estimated at €704M, with a burden per capita of €73. Higher age, women, comorbidities, surgery and less education were found to be significant predictors of higher costs. CONCLUSIONS: The societal burden of LBP is substantial and varies significantly between different types of patients. It is important to identify periods and interventions within a LBP-episode that can be relevantly adjusted in order to optimize cost-effectiveness of treatment, and also, to realize that results may be dependent on the time frame chosen for a LBP-episode. Acknowledgements: The study was financed with an unrestricted grant from Medtronic.

Conference/Value in Health Info

2015-11, ISPOR Europe 2015, Milan, Italy

Value in Health, Vol. 18, No. 7 (November 2015)

Code

PMS48

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Musculoskeletal Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×